Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
O'Donovan SM, Imami A, Eby H, Henkel ND, Creeden JF, Asah S, Zhang X, Wu X, Alnafisah R, Taylor RT, Reigle J, Thorman A, Shamsaei B, Meller J, McCullumsmith RE.
O'Donovan SM, et al.
Sci Rep. 2021 Feb 24;11(1):4495. doi: 10.1038/s41598-021-84044-9.
Sci Rep. 2021.
PMID: 33627767
Free PMC article.